Jesse C Patterson

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Dna Damage Response

Top Venues

bioRxiv : the preprint server for biology

Molecular cancer research : MCR

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin L Green, Lauren A Gamble, Laurence P Diggs, Darryl Nousome, Jesse C Patterson, Brian A Joughin, Billel Gasmi, Stephanie C Lux, Sarah G Samaranayake, Markku M Miettinen, Martha Quezado, Jonathan M Hernandez, Micheal B Yaffe, Jeremy Lee Davis
Early immune changes support signet ring cell dormancy in CDH1-driven hereditary diffuse gastric carcinogenesis. Molecular cancer research : MCR (2023)
Jung-Kuei Chen, Karl A Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George Eng, Erika D Handly, Jesse C Patterson, Ian G Cannell, Lucia Suarez-Lopez, Aaron M Hosios, Anh Dinh, Donald S Kirkpatrick, Kebing Yu, Christopher M Rose, Jonathan M Hernandez, Haeun Hwangbo, Adam C Palmer, Matthew G Vander Heiden, Ömer H Yilmaz, Micheal B Yaffe
An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types. bioRxiv : the preprint server for biology (2023)
Jung-Kuei Chen, Karl A Merrick, Yi Wen Kong, Anita Izrael-Tomasevic, George Eng, Erika D Handly, Jesse C Patterson, Ian G Cannell, Lucia Suarez-Lopez, Aaron M Hosios, Anh Dinh, Donald S Kirkpatrick, Kebing Yu, Christopher M Rose, Jonathan M Hernandez, Haeun Hwangbo, Adam C Palmer, Matthew G Vander Heiden, Ömer H Yilmaz, Micheal B Yaffe
An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types. bioRxiv : the preprint server for biology (2023)
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, Maya Ridinger, Susan L Dalrymple, Mannan Nouri, Fang Xie, Shohreh Varmeh, Oliver Jonas, Matthew A Whitman, Sen Chen, Saleh Rashed, Lovemore Makusha, Jun Luo, John T Isaacs, Mark G Erlander, David J Einstein, Steven P Balk, Micheal B Yaffe
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling. Cancer research (2022)